Phase 3 Critically Ill Patients Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
The SuDDICU Study of Antibiotic Prophylaxis in Critical Illness
Known or suspected infection in critically ill patients in the Intensive Care Unit (ICU)
The George Institute for Global Health15,000 enrolled18 locationsACTRN12615000411549
Completed
Phase 2Phase 3
Permissive HyperthErmiA Through Avoidance of Paracetamol in Known or Suspected Infection in the Intensive Care Unit (ICU)
Known or suspected infection in critically ill patients in the Intensive Care Unit (ICU)
Medical Research Institute of New Zealand700 enrolled1 locationACTRN12612000513819
Active
Phase 2Phase 3
Permissive HyperthErmia Through Avoidance of Paracetamol in Known or Suspected Infection in the Intensive Care Unit (ICU) - pilot study
Known or suspected infection in critically ill patients in ICU
Medical Research Institute of New Zealand30 enrolled1 locationACTRN12611000981921